The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Epirubicin Hydrochloride Market Research Report 2025
Synopsis
Epirubicin Hydrochloride is the hydrochloride salt of the 4'-epi-isomer of the anthracycline antineoplastic antibiotic doxorubicin. Epirubicin intercalates into DNA and inhibits topoisomerase II, thereby inhibiting DNA replication and ultimately, interfering with RNA and protein synthesis. This agent also produces toxic free-radical intermediates and interacts with cell membrane lipids causing lipid peroxidation.
The global Epirubicin Hydrochloride market was valued at US$ 253.2 million in 2023 and is anticipated to reach US$ 211.1 million by 2030, witnessing a CAGR of -2.5% during the forecast period 2024-2030.
Global core Epirubicin Hydrochloride players include Synbias Pharma, Zhejiang Hisun Pharma and Pfizer etc. The top 3 companies hold a share about 60%. Asia-Pacific is the largest market, with a share about 45%, followed by Europe and North America with the share about 25% and 20%.
In terms of product, 10mg/5ml is the largest segment, with a share about 45%, followed by 50mg/25ml, with a share about 40%. And in terms of application, the largest application is cancer, with a share about 95%, followed by others, with a share about 5%.
This report aims to provide a comprehensive presentation of the global market for Epirubicin Hydrochloride, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Epirubicin Hydrochloride.
Report Scope
The Epirubicin Hydrochloride market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Epirubicin Hydrochloride market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Epirubicin Hydrochloride manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sterling Biotech
Zhejiang Hisun Pharma
Flavine
Teva API
Microbiopharm Japan
DZD Heze Pharma
Synbias Pharma
Intas Pharma
Humble Healthcaare
Lunan Pharmaceutical Group
Pfizer
Beijing Union Pharmaceutical Factory
Segment by Type
10mg/5ml
50mg/25ml
Other
Segment by Application
Cancer
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Epirubicin Hydrochloride manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Epirubicin Hydrochloride in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Epirubicin Hydrochloride is the hydrochloride salt of the 4'-epi-isomer of the anthracycline antineoplastic antibiotic doxorubicin. Epirubicin intercalates into DNA and inhibits topoisomerase II, thereby inhibiting DNA replication and ultimately, interfering with RNA and protein synthesis. This agent also produces toxic free-radical intermediates and interacts with cell membrane lipids causing lipid peroxidation.
The global Epirubicin Hydrochloride market was valued at US$ 253.2 million in 2023 and is anticipated to reach US$ 211.1 million by 2030, witnessing a CAGR of -2.5% during the forecast period 2024-2030.
Global core Epirubicin Hydrochloride players include Synbias Pharma, Zhejiang Hisun Pharma and Pfizer etc. The top 3 companies hold a share about 60%. Asia-Pacific is the largest market, with a share about 45%, followed by Europe and North America with the share about 25% and 20%.
In terms of product, 10mg/5ml is the largest segment, with a share about 45%, followed by 50mg/25ml, with a share about 40%. And in terms of application, the largest application is cancer, with a share about 95%, followed by others, with a share about 5%.
This report aims to provide a comprehensive presentation of the global market for Epirubicin Hydrochloride, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Epirubicin Hydrochloride.
Report Scope
The Epirubicin Hydrochloride market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Epirubicin Hydrochloride market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Epirubicin Hydrochloride manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sterling Biotech
Zhejiang Hisun Pharma
Flavine
Teva API
Microbiopharm Japan
DZD Heze Pharma
Synbias Pharma
Intas Pharma
Humble Healthcaare
Lunan Pharmaceutical Group
Pfizer
Beijing Union Pharmaceutical Factory
Segment by Type
10mg/5ml
50mg/25ml
Other
Segment by Application
Cancer
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Epirubicin Hydrochloride manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Epirubicin Hydrochloride in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Epirubicin Hydrochloride Market Overview
1.1 Product Overview and Scope of Epirubicin Hydrochloride
1.2 Epirubicin Hydrochloride Segment by Type
1.2.1 Global Epirubicin Hydrochloride Market Value Comparison by Type (2024-2030)
1.2.2 10mg/5ml
1.2.3 50mg/25ml
1.2.4 Other
1.3 Epirubicin Hydrochloride Segment by Application
1.3.1 Global Epirubicin Hydrochloride Market Value by Application: (2024-2030)
1.3.2 Cancer
1.3.3 Others
1.4 Global Epirubicin Hydrochloride Market Size Estimates and Forecasts
1.4.1 Global Epirubicin Hydrochloride Revenue 2019-2030
1.4.2 Global Epirubicin Hydrochloride Sales 2019-2030
1.4.3 Global Epirubicin Hydrochloride Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Epirubicin Hydrochloride Market Competition by Manufacturers
2.1 Global Epirubicin Hydrochloride Sales Market Share by Manufacturers (2019-2024)
2.2 Global Epirubicin Hydrochloride Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Epirubicin Hydrochloride Average Price by Manufacturers (2019-2024)
2.4 Global Epirubicin Hydrochloride Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Epirubicin Hydrochloride, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Epirubicin Hydrochloride, Product Type & Application
2.7 Epirubicin Hydrochloride Market Competitive Situation and Trends
2.7.1 Epirubicin Hydrochloride Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Epirubicin Hydrochloride Players Market Share by Revenue
2.7.3 Global Epirubicin Hydrochloride Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Epirubicin Hydrochloride Retrospective Market Scenario by Region
3.1 Global Epirubicin Hydrochloride Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Epirubicin Hydrochloride Global Epirubicin Hydrochloride Sales by Region: 2019-2030
3.2.1 Global Epirubicin Hydrochloride Sales by Region: 2019-2024
3.2.2 Global Epirubicin Hydrochloride Sales by Region: 2025-2030
3.3 Global Epirubicin Hydrochloride Global Epirubicin Hydrochloride Revenue by Region: 2019-2030
3.3.1 Global Epirubicin Hydrochloride Revenue by Region: 2019-2024
3.3.2 Global Epirubicin Hydrochloride Revenue by Region: 2025-2030
3.4 North America Epirubicin Hydrochloride Market Facts & Figures by Country
3.4.1 North America Epirubicin Hydrochloride Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Epirubicin Hydrochloride Sales by Country (2019-2030)
3.4.3 North America Epirubicin Hydrochloride Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Epirubicin Hydrochloride Market Facts & Figures by Country
3.5.1 Europe Epirubicin Hydrochloride Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Epirubicin Hydrochloride Sales by Country (2019-2030)
3.5.3 Europe Epirubicin Hydrochloride Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Epirubicin Hydrochloride Market Facts & Figures by Country
3.6.1 Asia Pacific Epirubicin Hydrochloride Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Epirubicin Hydrochloride Sales by Country (2019-2030)
3.6.3 Asia Pacific Epirubicin Hydrochloride Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Epirubicin Hydrochloride Market Facts & Figures by Country
3.7.1 Latin America Epirubicin Hydrochloride Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Epirubicin Hydrochloride Sales by Country (2019-2030)
3.7.3 Latin America Epirubicin Hydrochloride Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Epirubicin Hydrochloride Market Facts & Figures by Country
3.8.1 Middle East and Africa Epirubicin Hydrochloride Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Epirubicin Hydrochloride Sales by Country (2019-2030)
3.8.3 Middle East and Africa Epirubicin Hydrochloride Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Epirubicin Hydrochloride Sales by Type (2019-2030)
4.1.1 Global Epirubicin Hydrochloride Sales by Type (2019-2024)
4.1.2 Global Epirubicin Hydrochloride Sales by Type (2025-2030)
4.1.3 Global Epirubicin Hydrochloride Sales Market Share by Type (2019-2030)
4.2 Global Epirubicin Hydrochloride Revenue by Type (2019-2030)
4.2.1 Global Epirubicin Hydrochloride Revenue by Type (2019-2024)
4.2.2 Global Epirubicin Hydrochloride Revenue by Type (2025-2030)
4.2.3 Global Epirubicin Hydrochloride Revenue Market Share by Type (2019-2030)
4.3 Global Epirubicin Hydrochloride Price by Type (2019-2030)
5 Segment by Application
5.1 Global Epirubicin Hydrochloride Sales by Application (2019-2030)
5.1.1 Global Epirubicin Hydrochloride Sales by Application (2019-2024)
5.1.2 Global Epirubicin Hydrochloride Sales by Application (2025-2030)
5.1.3 Global Epirubicin Hydrochloride Sales Market Share by Application (2019-2030)
5.2 Global Epirubicin Hydrochloride Revenue by Application (2019-2030)
5.2.1 Global Epirubicin Hydrochloride Revenue by Application (2019-2024)
5.2.2 Global Epirubicin Hydrochloride Revenue by Application (2025-2030)
5.2.3 Global Epirubicin Hydrochloride Revenue Market Share by Application (2019-2030)
5.3 Global Epirubicin Hydrochloride Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sterling Biotech
6.1.1 Sterling Biotech Corporation Information
6.1.2 Sterling Biotech Description and Business Overview
6.1.3 Sterling Biotech Epirubicin Hydrochloride Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sterling Biotech Epirubicin Hydrochloride Product Portfolio
6.1.5 Sterling Biotech Recent Developments/Updates
6.2 Zhejiang Hisun Pharma
6.2.1 Zhejiang Hisun Pharma Corporation Information
6.2.2 Zhejiang Hisun Pharma Description and Business Overview
6.2.3 Zhejiang Hisun Pharma Epirubicin Hydrochloride Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Zhejiang Hisun Pharma Epirubicin Hydrochloride Product Portfolio
6.2.5 Zhejiang Hisun Pharma Recent Developments/Updates
6.3 Flavine
6.3.1 Flavine Corporation Information
6.3.2 Flavine Description and Business Overview
6.3.3 Flavine Epirubicin Hydrochloride Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Flavine Epirubicin Hydrochloride Product Portfolio
6.3.5 Flavine Recent Developments/Updates
6.4 Teva API
6.4.1 Teva API Corporation Information
6.4.2 Teva API Description and Business Overview
6.4.3 Teva API Epirubicin Hydrochloride Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Teva API Epirubicin Hydrochloride Product Portfolio
6.4.5 Teva API Recent Developments/Updates
6.5 Microbiopharm Japan
6.5.1 Microbiopharm Japan Corporation Information
6.5.2 Microbiopharm Japan Description and Business Overview
6.5.3 Microbiopharm Japan Epirubicin Hydrochloride Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Microbiopharm Japan Epirubicin Hydrochloride Product Portfolio
6.5.5 Microbiopharm Japan Recent Developments/Updates
6.6 DZD Heze Pharma
6.6.1 DZD Heze Pharma Corporation Information
6.6.2 DZD Heze Pharma Description and Business Overview
6.6.3 DZD Heze Pharma Epirubicin Hydrochloride Sales, Revenue and Gross Margin (2019-2024)
6.6.4 DZD Heze Pharma Epirubicin Hydrochloride Product Portfolio
6.6.5 DZD Heze Pharma Recent Developments/Updates
6.7 Synbias Pharma
6.6.1 Synbias Pharma Corporation Information
6.6.2 Synbias Pharma Description and Business Overview
6.6.3 Synbias Pharma Epirubicin Hydrochloride Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Synbias Pharma Epirubicin Hydrochloride Product Portfolio
6.7.5 Synbias Pharma Recent Developments/Updates
6.8 Intas Pharma
6.8.1 Intas Pharma Corporation Information
6.8.2 Intas Pharma Description and Business Overview
6.8.3 Intas Pharma Epirubicin Hydrochloride Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Intas Pharma Epirubicin Hydrochloride Product Portfolio
6.8.5 Intas Pharma Recent Developments/Updates
6.9 Humble Healthcaare
6.9.1 Humble Healthcaare Corporation Information
6.9.2 Humble Healthcaare Description and Business Overview
6.9.3 Humble Healthcaare Epirubicin Hydrochloride Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Humble Healthcaare Epirubicin Hydrochloride Product Portfolio
6.9.5 Humble Healthcaare Recent Developments/Updates
6.10 Lunan Pharmaceutical Group
6.10.1 Lunan Pharmaceutical Group Corporation Information
6.10.2 Lunan Pharmaceutical Group Description and Business Overview
6.10.3 Lunan Pharmaceutical Group Epirubicin Hydrochloride Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Lunan Pharmaceutical Group Epirubicin Hydrochloride Product Portfolio
6.10.5 Lunan Pharmaceutical Group Recent Developments/Updates
6.11 Pfizer
6.11.1 Pfizer Corporation Information
6.11.2 Pfizer Epirubicin Hydrochloride Description and Business Overview
6.11.3 Pfizer Epirubicin Hydrochloride Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Pfizer Epirubicin Hydrochloride Product Portfolio
6.11.5 Pfizer Recent Developments/Updates
6.12 Beijing Union Pharmaceutical Factory
6.12.1 Beijing Union Pharmaceutical Factory Corporation Information
6.12.2 Beijing Union Pharmaceutical Factory Epirubicin Hydrochloride Description and Business Overview
6.12.3 Beijing Union Pharmaceutical Factory Epirubicin Hydrochloride Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Beijing Union Pharmaceutical Factory Epirubicin Hydrochloride Product Portfolio
6.12.5 Beijing Union Pharmaceutical Factory Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Epirubicin Hydrochloride Industry Chain Analysis
7.2 Epirubicin Hydrochloride Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Epirubicin Hydrochloride Production Mode & Process
7.4 Epirubicin Hydrochloride Sales and Marketing
7.4.1 Epirubicin Hydrochloride Sales Channels
7.4.2 Epirubicin Hydrochloride Distributors
7.5 Epirubicin Hydrochloride Customers
8 Epirubicin Hydrochloride Market Dynamics
8.1 Epirubicin Hydrochloride Industry Trends
8.2 Epirubicin Hydrochloride Market Drivers
8.3 Epirubicin Hydrochloride Market Challenges
8.4 Epirubicin Hydrochloride Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
